Search - [Diabetes Open Directory]

DOD

Discussions

Biomedical Jobmarket

News

DOD Alert

Edit DOD

ACCOUNT

Forgotten Password?

Or restrict your search to:
	Discussion articles	Comments	Journal articles
	Discussions	Availabilities	Job Applications
	Announcements/ Conferences	Grants/Funds	Information/News

Your search for: 'Kolterman* AND Buse* AND Fineman* AND Gaines* AND Heintz* AND Bicsak* AND Synthetic* AND significantly* AND reduces* AND postprandial* AND fasting* AND plasma* AND glucose* AND subjects* AND with* AND type* AND diabetes*'

Documents 1 - 1 of 1 matches

1. (Journal Article): Synthetic exendin-4 (exenatide) significantly re-duces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD

ABSTRACT: Despite the advent of new treatments, glucose control in the type 2 diabetes population is unsatisfactory. AC2993 (synthetic exendin-4; exenatide), a novel glucose-dependent insuli...

» Diabetes OD » Disease Management » T2DM » Metabolic Control » Anti-Hyperglycemic a... » Incretin Hormones » Incretin Mimetics » Exenatide » Human Studies » Journal Article
submitted: Nov 29, 2005

Result pages:

About DOD | Advertising Information | Support The Project | DOD alert | Become Editor